Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;36(3):551-560.
doi: 10.1111/jgh.15413.

Artificial intelligence in the diagnosis and management of hepatocellular carcinoma

Masaya Sato  1   2 , Ryosuke Tateishi  2 , Yutaka Yatomi  1 , Kazuhiko Koike  2
Affiliations

Artificial intelligence in the diagnosis and management of hepatocellular carcinoma

Masaya Sato et al. J Gastroenterol Hepatol. 2021 Mar.

Abstract

Despite recent improvements in therapeutic interventions, hepatocellular carcinoma is still associated with a poor prognosis in patients with an advanced disease at diagnosis. Recently, significant progress has been made in image recognition through advances in the field of artificial intelligence (AI) (or machine learning), especially deep learning. AI is a multidisciplinary field that draws on the fields of computer science and mathematics for developing and implementing computer algorithms capable of maximizing the predictive accuracy from static or dynamic data sources using analytic or probabilistic models. Because of the multifactorial and complex nature of liver diseases, the machine learning approach to integrate multiple factors would appear to be an advantageous approach to improve the likelihood of making a precise diagnosis and predicting the response of treatment and prognosis of liver diseases. In this review, we attempted to summarize the potential use of AI in the diagnosis and management of liver diseases, especially hepatocellular carcinoma.

Keywords: artificial intelligence; deep learning; hepatocellular carcinoma; machine learning; predictive model.

PubMed Disclaimer

References

    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
    1. Kudo M, Izumi N, Sakamoto M et al. Survival analysis over 28 years of 173,378 patients with hepatocellular carcinoma in Japan. Liver Cancer 2016; 5: 190-197. https://doi.org/10.1159/000367775
    1. Trevisani F, Cantarini MC, Wands JR, Bernardi M. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 2008; 29: 1299-1305. https://doi.org/10.1093/carcin/bgn113
    1. Krizhevsky A, Sutskever I, Hinton GE. IImagenet classification with deep convolutional neural networks. Adv. Neural. Inform. Process. Syst. 2012; 1097-1105.
    1. Mori Y, Kudo SE, Misawa M et al. Real-time use of artificial intelligence in identification of diminutive polyps during colonoscopy: a prospective study. Ann. Intern. Med. 2018; 169: 357-366. https://doi.org/10.7326/m18-0249

LinkOut - more resources